James E. Lillie - 30 Jul 2025 Form 4 Insider Report for ACUREN CORP (TIC)

Role
Director
Signature
/s/ Fiona Sutherland, Attorney-in-Fact
Issuer symbol
TIC
Transactions as of
30 Jul 2025
Net transactions value
$0
Form type
4
Filing time
01 Aug 2025, 18:29:52 UTC
Previous filing
17 Jun 2025
Next filing
13 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LILLIE JAMES E Director C/O ACUREN CORPORATION, 14434 MEDICAL COMPLEX DRIVE, SUITE 100, TOMBALL /s/ Fiona Sutherland, Attorney-in-Fact 01 Aug 2025 0001164470

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TIC Common Stock Options Exercise $0 +10,000 $0.000000 10,000 30 Jul 2025 Direct F1
holding TIC Common Stock 1,746,169 30 Jul 2025 By Mariposa Acquisition IX, LLC F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TIC Restricted Stock Units Options Exercise $0 -10,000 -100% $0.000000 0 30 Jul 2025 Common Stock 10,000 Direct F3, F4
transaction TIC Restricted Stock Units Award $0 +9,017 $0.000000 9,017 31 Jul 2025 Common Stock 9,017 Direct F3, F5
holding TIC Series A Preferred Stock 92,500 30 Jul 2025 Common Stock 92,500 By Mariposa Acquisition IX, LLC F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 30, 2025, 10,000 of the Reporting Person's restricted stock units were settled for an equal number of shares of the Issuer's Common Stock.
F2 Mariposa Acquisition IX, LLC ("Mariposa IX") directly holds (i) 18,877,500 shares of Common Stock and (ii) 1,000,000 shares of Series A Preferred Stock ("Preferred Stock") convertible into shares of Common Stock for no additional consideration as set forth below. Mr. Lillie holds a limited liability company interest in Mariposa IX and, as a result, may be deemed to have a pecuniary interest in approximately (i) 1,746,169 shares of Common Stock and (ii) 92,500 shares of Common Stock issuable upon conversion of the Preferred Stock held by Mariposa IX. Mr. Lillie disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by Mariposa IX except to the extent of his pecuniary interest therein. Mr. Lillie does not have beneficial ownership over the shares of Common Stock and Preferred Stock held directly by Mariposa IX.
F3 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F4 These restricted stock units vest on July 30, 2025 (the one-year anniversary of the grant date).
F5 These restricted stock units vest on July 31, 2026 (the one-year anniversary of the grant date).
F6 The Series A Preferred Stock is convertible at any time at the election of the holder, on a one-for-one basis, into shares of Common Stock for no additional consideration. The Series A Preferred Stock shall automatically convert into Common Stock upon the earlier of (i) immediately following the "change of control dividend date" (as defined in the Issuer's certificate of incorporation) and (ii) December 31, 2034.